Federal health officials issued a warning Tuesday over misleading statements made by biotech billionaire Dr. Patrick ...

ImmunityBio Inc.’s shares plunged after the biotechnology company and its billionaire executive chairman, Patrick Soon-Shiong ...

Federal health officials issued a warning Tuesday over misleading statements made by biotech billionaire Patrick Soon-Shiong, ...

UIC researchers have successfully repurposed an FDA-approved cancer drug, doxorubicin, to treat drug-resistant strains of ...

SNV4818 is an oral treatment currently being evaluated in an early and mid-stage study for breast cancer and other advanced ...

March 24 (Reuters) - The European Union's medicines regulator said on Tuesday it expects Baxter International's cancer drugs ...

Pegvisomant, developed by professor John Kopchick in 1987, shows potential to make treatment-resistant lung cancer cells more ...

At 69 years old, Debby Orcutt was diagnosed last year with pancreatic cancer, a condition so dire that her doctor refused to tell her how long she had to live. With few good options, she enrolled in a ...

Recent advances in drug discovery research have led to the development of numerous drug candidate compounds with high ...

A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

Evidence shows that birth control pills containing the hormones estrogen and progestin can increase the risk of different types of cancers and decrease the risk of others.  Since 1999, the World ...

Swiss drugmaker Novartis on Friday agreed to buy a breast cancer drug candidate for up to $3 billion from U.S. biotech firm ...